Institution
Rutgers Cancer Institute
Also known as: Cancer Institute of New Jersey · Rutgers Cancer Center · Rutgers Cancer Institute of New Jersey · Rutgers University Cancer Institute of New Jersey
- 326running trials
- 91closed trials
- 1researcher
- 11,101publications (OpenAlex)
Researchers
Running trials
Not yet recruiting
Phase II De-Escalation Study of Metronomic Decitabine/Cedazuridine Plus Venetoclax in AML
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Sun Safe Together: A Digital Skin Cancer Prevention Intervention for Adolescents and Their Parents
Recruiting
Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)
Recruiting
Recruiting
Enrolling by invitation
Pilot Testing a Web-based Prototype of a Lung Cancer Screening Digital Health Tool
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Recruiting
Recruiting
Recruiting
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Recruiting
Recruiting
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Enrolling by invitation
Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
Recruiting
Recruiting
Recruiting
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
Recruiting
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Recruiting
Active, not recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
Recruiting
Recruiting
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Recruiting
Recruiting
Recruiting
Not yet recruiting
Trial of ctDNA of Guidance to Determine PostOperative Radiation Therapy
Showing 50 of 326.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer22 recruiting
- Bladder cancer15 recruiting
- Colorectal cancer13 recruiting
- Childhood cancers12 recruiting
- Acute myeloid leukaemia10 recruiting
- Melanoma10 recruiting
- Ovarian cancer10 recruiting
- Head and neck cancer9 recruiting
- Prostate cancer8 recruiting
- Multiple myeloma7 recruiting
- Metastatic breast cancer6 recruiting
- Pancreatic cancer6 recruiting
- Acute lymphoblastic leukaemia5 recruiting
- Follicular lymphoma5 recruiting
- Myelodysplastic syndromes5 recruiting
- Sarcoma5 recruiting
- Cervical cancer4 recruiting
- Diffuse large B-cell lymphoma4 recruiting
- Endometrial cancer4 recruiting
- Gastric and oesophageal cancer4 recruiting
- Glioblastoma4 recruiting
- Liver and biliary tract cancer4 recruiting
- Triple-negative breast cancer4 recruiting
- Chronic lymphocytic leukaemia3 recruiting
- Kidney cancer3 recruiting
- Mantle cell lymphoma3 recruiting
- Myeloproliferative neoplasms3 recruiting
- Chronic myeloid leukaemia2 recruiting
- Aplastic anaemia1 recruiting
- Brain metastases1 recruiting
- Burkitt lymphoma1 recruiting
- Crohn's disease1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Down syndrome1 recruiting
- Familial hypercholesterolaemia1 recruiting
- High blood pressure1 recruiting
- Hodgkin lymphoma1 recruiting
- Lupus (SLE)1 recruiting
- Mesothelioma1 recruiting
- Multiple sclerosis1 recruiting
- Neuroblastoma1 recruiting
- Neuroendocrine tumours1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Rheumatoid arthritis1 recruiting
- Sickle cell disease1 recruiting
- Sjögren's disease1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Testicular cancer1 recruiting
- Type 1 diabetes1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Withdrawn
Withdrawn
A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants
Terminated
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Completed
Terminated
Recruiting
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Terminated
Completed
Terminated
Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC
Terminated
Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.
Completed
First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors
Terminated
Terminated
Completed
Completed
A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer
Completed
Withdrawn
Completed
Terminated
Withdrawn
Recruiting
Completed
Completed
Completed
Recruiting
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Completed
Completed
Completed
A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer
Terminated
Terminated
A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH
Completed
A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
Completed
Completed
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
Completed
Completed
Completed
Completed
Withdrawn
Terminated
Completed
Completed
Completed
Trial of Maintenance With Niraparib- Uterine Serous Carcinoma
Completed
Completed
Completed
Terminated
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
Terminated
Terminated
Completed
Completed
Showing 50 of 91.
Registry name variants (54)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey 08903
324 trials
Rutgers Cancer Institute
New Brunswick, New Jersey 08901
41 trials
Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
4 trials
Rutgers Cancer Institute of New Jersey (Site 0033)
New Brunswick, New Jersey 08903
4 trials
Rutgers Cancer Institute of New Jersey
Newark, New Jersey 07103
2 trials
Robert Wood Johnson/Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
1 trial
NCT01351545A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Contact: Matthew Matasar, MD, MS
Rutgers Cancer Institute, 195 Little Albany Street
New Brunswick, New Jersey 08903
1 trial
NCT03567889Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Contact: Adam Berger
Rutgers Cancer Institute of New Jersey
Piscataway, New Jersey 08854
1 trial
Contact: Professor Adam Berger
Rutgers Cancer Institute of New Jersey,110 Rehill Ave
Somerville, New Jersey 08876
1 trial
Rutgers Cancer Institute of New Jersey - Cancer Center
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey / Jack and Sheryl Morris Cancer Center
New Brunswick, New Jersey 08901
1 trial
Contact: Alicia Moore
Rutgers Cancer Institute of New Jersey (Site 0005)
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey (Site 0007)
New Brunswick, New Jersey 08901
1 trial
NCT07222488A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Contact: Study Coordinator
Rutgers Cancer Institute of New Jersey (Site 0009)
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey (Site 0027)
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey (Site 0052)
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey (Site 0054)
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey (Site 0059)
New Brunswick, New Jersey 08903
1 trial
Rutgers Cancer Institute of New Jersey (Site 0071)
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey (Site 0073)
New Brunswick, New Jersey 08903
1 trial
Rutgers Cancer Institute of New Jersey (Site 0076)
New Brunswick, New Jersey 08901
1 trial
Contact: Study Coordinator
Rutgers Cancer Institute of New Jersey (Site 0078)
New Brunswick, New Jersey 08903
1 trial
Rutgers Cancer Institute of New Jersey (Site 0100)
New Brunswick, New Jersey 08901
1 trial
Contact: Study Coordinator
Rutgers Cancer Institute of New Jersey (Site 0114)
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey (Site 0123)
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey (Site 0635)
New Brunswick, New Jersey 08903
1 trial
Rutgers Cancer Institute of New Jersey (Site 0695)
New Brunswick, New Jersey 08903
1 trial
Rutgers Cancer Institute of New Jersey (Site 1008)
New Brunswick, New Jersey 08903
1 trial
Rutgers Cancer Institute of New Jersey (Site 103)
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey (Site 1059)
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey (Site 1105)
New Brunswick, New Jersey 08903
1 trial
Rutgers Cancer Institute of New Jersey (Site 1422)
New Brunswick, New Jersey 08903
1 trial
Rutgers Cancer Institute of New Jersey (Site 1523)
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey (Site 2008)
New Brunswick, New Jersey 08903
1 trial
Rutgers Cancer Institute of New Jersey (Site 2071)
New Brunswick, New Jersey 08903
1 trial
Rutgers Cancer Institute of New Jersey (Site 2217)
New Brunswick, New Jersey 08903
1 trial
Rutgers Cancer Institute of New Jersey (Site 2805)
New Brunswick, New Jersey 08901
1 trial
Rutgers Cancer Institute of New Jersey (Site 3008)
New Brunswick, New Jersey 08901
1 trial
Contact: Study Coordinator
Rutgers Cancer Institute of New Jersey (Site 3541)
New Brunswick, New Jersey 08903
1 trial
Rutgers Cancer Institute of New Jersey (Site 4008)
New Brunswick, New Jersey 08901
1 trial
Contact: Study Coordinator
Rutgers Cancer Institute of New Jersey University
New Brunswick, New Jersey 08901
1 trial
Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School - The Cancer Institute of New Jersey (CINJ)
New Brunswick, New Jersey 08901
1 trial
Rutger's University / Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
1 trial
Rutgers University - Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
1 trial
Rutgers University/Rutgers Cancer Institute
New Brunswick, New Jersey 08903
1 trial
NCT07618520Expanding Genetic Access for Prostate Cancer Survivors
Contact: Anita Kinney, PhD
The Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
1 trial
The Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey 08903
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Prostate cancer52 works · 32 trials
- Hodgkin lymphoma32 works · 6 trials
- Bladder cancer29 works · 25 trials
- Acute lymphoblastic leukaemia13 works · 12 trials
- Diffuse large B-cell lymphoma11 works · 13 trials
- Chronic lymphocytic leukaemia8 works · 12 trials
- Mantle cell lymphoma8 works · 5 trials
- Follicular lymphoma5 works · 10 trials
Institution data: ROR 0060x3y55 (CC0-1.0)Updated 15 Nov 2026